| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Alzheimer Disease | 8 | 2019 | 1020 | 1.81 | Why? |
| Amyloid beta-Peptides | 6 | 2019 | 185 | 1.42 | Why? |
| Total Quality Management | 2 | 2018 | 50 | 1.41 | Why? |
| Quality Assurance, Health Care | 2 | 2018 | 596 | 0.95 | Why? |
| Immunoglobulin A | 3 | 2020 | 3567 | 0.83 | Why? |
| Troponin I | 2 | 2019 | 1298 | 0.83 | Why? |
| Cardiac-Gated Imaging Techniques | 1 | 2019 | 25 | 0.78 | Why? |
| Serum Amyloid A Protein | 1 | 2021 | 211 | 0.78 | Why? |
| Peptide Fragments | 7 | 2019 | 2075 | 0.76 | Why? |
| Electrophoresis, Capillary | 1 | 2018 | 39 | 0.74 | Why? |
| Bromelains | 1 | 2018 | 37 | 0.71 | Why? |
| Neuroprotective Agents | 2 | 2018 | 240 | 0.68 | Why? |
| Automation, Laboratory | 1 | 2019 | 536 | 0.64 | Why? |
| Chromatography, High Pressure Liquid | 2 | 2018 | 669 | 0.63 | Why? |
| Phlebotomy | 1 | 2017 | 131 | 0.61 | Why? |
| Blood Chemical Analysis | 1 | 2019 | 541 | 0.56 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.56 | Why? |
| Proteolysis | 1 | 2018 | 751 | 0.52 | Why? |
| tau Proteins | 3 | 2019 | 162 | 0.51 | Why? |
| Troponin T | 1 | 2019 | 771 | 0.51 | Why? |
| Pathology, Clinical | 1 | 2017 | 407 | 0.47 | Why? |
| Proteins | 1 | 2019 | 921 | 0.45 | Why? |
| Clinical Laboratory Services | 1 | 2018 | 781 | 0.43 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.41 | Why? |
| Glycated Hemoglobin A | 1 | 2018 | 1316 | 0.41 | Why? |
| Orexins | 2 | 2019 | 21 | 0.38 | Why? |
| Biomarkers | 17 | 2021 | 23361 | 0.38 | Why? |
| Muscle Development | 2 | 2018 | 27 | 0.36 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.36 | Why? |
| Occult Blood | 1 | 2011 | 275 | 0.35 | Why? |
| Biological Assay | 1 | 2011 | 367 | 0.35 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.34 | Why? |
| Reference Values | 3 | 2019 | 795 | 0.34 | Why? |
| Artificial Intelligence | 2 | 2020 | 3543 | 0.34 | Why? |
| Sensitivity and Specificity | 9 | 2021 | 22971 | 0.33 | Why? |
| Myocardium | 1 | 2019 | 2323 | 0.33 | Why? |
| Quality Control | 3 | 2019 | 628 | 0.30 | Why? |
| Laboratories | 1 | 2018 | 2858 | 0.30 | Why? |
| Tissue Engineering | 2 | 2017 | 190 | 0.29 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.29 | Why? |
| DNA | 1 | 2011 | 778 | 0.28 | Why? |
| Leukocyte L1 Antigen Complex | 2 | 2021 | 238 | 0.28 | Why? |
| Electrocardiography | 1 | 2019 | 3957 | 0.28 | Why? |
| Metabolomics | 3 | 2019 | 921 | 0.27 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.26 | Why? |
| Myoblasts | 2 | 2018 | 24 | 0.22 | Why? |
| Plasminogen | 1 | 2021 | 58 | 0.22 | Why? |
| Gene Products, env | 1 | 2021 | 74 | 0.22 | Why? |
| Pregnancy Proteins | 1 | 2021 | 43 | 0.22 | Why? |
| Receptor, EphB3 | 1 | 2019 | 1 | 0.21 | Why? |
| Immunoassay | 3 | 2021 | 4485 | 0.20 | Why? |
| Bence Jones Protein | 1 | 2018 | 2 | 0.20 | Why? |
| Clinical Laboratory Techniques | 5 | 2020 | 23402 | 0.20 | Why? |
| Nephelometry and Turbidimetry | 1 | 2018 | 25 | 0.20 | Why? |
| Immunoglobulin kappa-Chains | 1 | 2018 | 12 | 0.19 | Why? |
| MyoD Protein | 1 | 2018 | 2 | 0.19 | Why? |
| Humans | 56 | 2021 | 930598 | 0.19 | Why? |
| Flecainide | 1 | 2018 | 4 | 0.19 | Why? |
| Luteolin | 1 | 2019 | 70 | 0.19 | Why? |
| Myotonic Disorders | 1 | 2018 | 4 | 0.19 | Why? |
| Reproducibility of Results | 3 | 2021 | 11304 | 0.19 | Why? |
| Supranuclear Palsy, Progressive | 1 | 2018 | 20 | 0.19 | Why? |
| Vacuoles | 1 | 2018 | 36 | 0.18 | Why? |
| Glycogen Storage Disease Type II | 1 | 2018 | 26 | 0.18 | Why? |
| Tissue Scaffolds | 2 | 2017 | 174 | 0.18 | Why? |
| Immunoglobulin Light Chains | 1 | 2018 | 62 | 0.18 | Why? |
| Adrenomedullin | 2 | 2019 | 217 | 0.18 | Why? |
| Voltage-Gated Sodium Channel Blockers | 1 | 2018 | 29 | 0.18 | Why? |
| alpha-Glucosidases | 1 | 2018 | 39 | 0.18 | Why? |
| H-Reflex | 1 | 2017 | 2 | 0.18 | Why? |
| alpha-Synuclein | 1 | 2018 | 71 | 0.18 | Why? |
| Keratinocytes | 1 | 2019 | 119 | 0.18 | Why? |
| Protein Aggregation, Pathological | 1 | 2018 | 36 | 0.18 | Why? |
| Protein Aggregates | 1 | 2018 | 51 | 0.18 | Why? |
| Medical Laboratory Science | 1 | 2019 | 122 | 0.18 | Why? |
| Immunologic Tests | 1 | 2021 | 445 | 0.18 | Why? |
| Molecular Weight | 1 | 2018 | 249 | 0.17 | Why? |
| Basigin | 1 | 2020 | 276 | 0.17 | Why? |
| Drug Trafficking | 1 | 2017 | 22 | 0.17 | Why? |
| Levamisole | 1 | 2017 | 24 | 0.17 | Why? |
| Middle Aged | 31 | 2021 | 270681 | 0.17 | Why? |
| Bioprinting | 1 | 2017 | 17 | 0.17 | Why? |
| Hypothalamus | 1 | 2017 | 58 | 0.17 | Why? |
| Aging, Premature | 1 | 2016 | 11 | 0.17 | Why? |
| Proteomics | 2 | 2019 | 2481 | 0.17 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2018 | 222 | 0.17 | Why? |
| Motor Skills | 1 | 2017 | 57 | 0.17 | Why? |
| Tremor | 1 | 2017 | 89 | 0.17 | Why? |
| Protein Precursors | 2 | 2019 | 425 | 0.17 | Why? |
| Phenylethyl Alcohol | 1 | 2017 | 74 | 0.17 | Why? |
| Automation | 1 | 2019 | 429 | 0.17 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.17 | Why? |
| Cocaine | 1 | 2017 | 73 | 0.16 | Why? |
| Nevus | 1 | 2016 | 42 | 0.16 | Why? |
| Feces | 1 | 2011 | 4235 | 0.16 | Why? |
| Drug Contamination | 1 | 2017 | 104 | 0.16 | Why? |
| Abortion, Habitual | 1 | 2016 | 35 | 0.16 | Why? |
| Colorectal Neoplasms | 1 | 2011 | 1884 | 0.16 | Why? |
| Haplotypes | 1 | 2020 | 853 | 0.16 | Why? |
| Serologic Tests | 2 | 2021 | 4359 | 0.16 | Why? |
| ROC Curve | 3 | 2021 | 6024 | 0.16 | Why? |
| Central Nervous System Stimulants | 1 | 2017 | 111 | 0.16 | Why? |
| Myotonic Dystrophy | 1 | 2016 | 51 | 0.16 | Why? |
| Primary Cell Culture | 1 | 2018 | 501 | 0.16 | Why? |
| Cerebrospinal Fluid | 1 | 2018 | 234 | 0.15 | Why? |
| Aged | 24 | 2021 | 215776 | 0.15 | Why? |
| Healthy Volunteers | 2 | 2019 | 1444 | 0.15 | Why? |
| Antibody Specificity | 1 | 2020 | 1328 | 0.15 | Why? |
| Rats, Wistar | 1 | 2018 | 621 | 0.15 | Why? |
| Cell Differentiation | 2 | 2021 | 1338 | 0.15 | Why? |
| C-Reactive Protein | 3 | 2021 | 7972 | 0.15 | Why? |
| Hydrogels | 1 | 2017 | 173 | 0.15 | Why? |
| Drug Compounding | 1 | 2017 | 386 | 0.14 | Why? |
| Cerebral Cortex | 1 | 2018 | 276 | 0.14 | Why? |
| Protein Stability | 1 | 2018 | 756 | 0.14 | Why? |
| Glucosides | 1 | 2019 | 359 | 0.14 | Why? |
| Energy Metabolism | 1 | 2019 | 451 | 0.14 | Why? |
| Neurotoxins | 1 | 2014 | 42 | 0.14 | Why? |
| Transforming Growth Factor beta | 1 | 2017 | 363 | 0.14 | Why? |
| Glutamic Acid | 1 | 2014 | 65 | 0.14 | Why? |
| Antibodies, Antinuclear | 1 | 2016 | 234 | 0.14 | Why? |
| Blood Gas Analysis | 1 | 2018 | 893 | 0.14 | Why? |
| Antiphospholipid Syndrome | 1 | 2021 | 533 | 0.14 | Why? |
| Blood Cell Count | 1 | 2020 | 1101 | 0.14 | Why? |
| HLA Antigens | 1 | 2020 | 830 | 0.14 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.13 | Why? |
| Lithium | 1 | 2014 | 56 | 0.13 | Why? |
| Sleep Apnea Syndromes | 1 | 2017 | 282 | 0.13 | Why? |
| False Negative Reactions | 1 | 2021 | 1785 | 0.13 | Why? |
| Valproic Acid | 1 | 2014 | 114 | 0.13 | Why? |
| Body Composition | 1 | 2017 | 414 | 0.13 | Why? |
| Male | 29 | 2021 | 367725 | 0.13 | Why? |
| Lab-On-A-Chip Devices | 1 | 2017 | 411 | 0.13 | Why? |
| Furin | 1 | 2020 | 1054 | 0.12 | Why? |
| Early Diagnosis | 2 | 2019 | 2443 | 0.12 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.12 | Why? |
| Female | 26 | 2021 | 380317 | 0.12 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.12 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.12 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.12 | Why? |
| Polysomnography | 3 | 2018 | 296 | 0.11 | Why? |
| Nucleic Acid Denaturation | 1 | 2011 | 29 | 0.11 | Why? |
| Adult | 18 | 2021 | 244371 | 0.11 | Why? |
| Ascorbic Acid | 1 | 2017 | 676 | 0.11 | Why? |
| Alanine Transaminase | 1 | 2017 | 1329 | 0.11 | Why? |
| Sleep Apnea, Obstructive | 1 | 2019 | 668 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.10 | Why? |
| Neuroblastoma | 2 | 2014 | 91 | 0.10 | Why? |
| Lung Diseases, Interstitial | 1 | 2021 | 1476 | 0.10 | Why? |
| Apoptosis | 1 | 2020 | 2335 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.10 | Why? |
| Parkinson Disease | 2 | 2018 | 1414 | 0.10 | Why? |
| Multiple Myeloma | 1 | 2018 | 1064 | 0.09 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.09 | Why? |
| Real-Time Polymerase Chain Reaction | 4 | 2021 | 11367 | 0.09 | Why? |
| Adenoma | 1 | 2011 | 215 | 0.09 | Why? |
| Neurons | 1 | 2014 | 864 | 0.09 | Why? |
| Medicine, Chinese Traditional | 1 | 2020 | 2255 | 0.09 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.09 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 5993 | 0.08 | Why? |
| Antioxidants | 1 | 2017 | 1593 | 0.08 | Why? |
| Hyperglycemia | 1 | 2018 | 1363 | 0.08 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.08 | Why? |
| Gene Expression Regulation | 2 | 2017 | 4020 | 0.08 | Why? |
| Disease Progression | 3 | 2021 | 13580 | 0.08 | Why? |
| Muscle, Skeletal | 3 | 2018 | 915 | 0.08 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.08 | Why? |
| Electromyography | 2 | 2018 | 278 | 0.08 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.08 | Why? |
| Interleukin-6 | 2 | 2021 | 7522 | 0.08 | Why? |
| Embryonic Induction | 1 | 2005 | 1 | 0.08 | Why? |
| Sleep Wake Disorders | 1 | 2017 | 1463 | 0.08 | Why? |
| Xenopus laevis | 1 | 2005 | 14 | 0.08 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.07 | Why? |
| Hepatitis C | 1 | 2017 | 1514 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.07 | Why? |
| Lens, Crystalline | 1 | 2005 | 14 | 0.07 | Why? |
| Lactic Acid | 2 | 2019 | 393 | 0.07 | Why? |
| Phosphorylation | 2 | 2019 | 1060 | 0.07 | Why? |
| Epidermis | 1 | 2005 | 47 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.07 | Why? |
| Italy | 5 | 2021 | 38444 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.07 | Why? |
| Lymphocytes | 1 | 2018 | 3056 | 0.07 | Why? |
| Sleep | 1 | 2018 | 2695 | 0.07 | Why? |
| Point-of-Care Systems | 1 | 2018 | 2955 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.07 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.07 | Why? |
| Etoposide | 1 | 2005 | 115 | 0.07 | Why? |
| Skin | 1 | 2016 | 2096 | 0.07 | Why? |
| Colonoscopy | 1 | 2011 | 738 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2018 | 1969 | 0.07 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.06 | Why? |
| Regression Analysis | 1 | 2011 | 2484 | 0.06 | Why? |
| Antineoplastic Agents, Phytogenic | 1 | 2005 | 183 | 0.06 | Why? |
| Emergency Service, Hospital | 4 | 2021 | 14232 | 0.06 | Why? |
| Skin Neoplasms | 1 | 2016 | 1679 | 0.06 | Why? |
| Multiple Sclerosis | 1 | 2018 | 2600 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2021 | 243684 | 0.06 | Why? |
| Area Under Curve | 2 | 2020 | 2564 | 0.06 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.06 | Why? |
| Skin Diseases | 1 | 2018 | 2509 | 0.06 | Why? |
| Annexin A5 | 1 | 2021 | 22 | 0.06 | Why? |
| Triage | 1 | 2021 | 7151 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| MicroRNAs | 1 | 2014 | 1787 | 0.06 | Why? |
| Drug Resistance, Neoplasm | 1 | 2005 | 447 | 0.05 | Why? |
| Vitamin D | 1 | 2016 | 2904 | 0.05 | Why? |
| Endogenous Retroviruses | 1 | 2021 | 72 | 0.05 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.05 | Why? |
| Hexokinase | 1 | 2019 | 10 | 0.05 | Why? |
| Mutation | 1 | 2020 | 12376 | 0.05 | Why? |
| Antibodies, Anticardiolipin | 1 | 2021 | 208 | 0.05 | Why? |
| Myogenin | 1 | 2018 | 4 | 0.05 | Why? |
| Viral Nonstructural Proteins | 1 | 2017 | 4810 | 0.05 | Why? |
| Exome | 1 | 2020 | 207 | 0.05 | Why? |
| Myosin Heavy Chains | 1 | 2018 | 26 | 0.05 | Why? |
| Validation Studies as Topic | 1 | 2019 | 121 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| Erythrocyte Indices | 1 | 2020 | 207 | 0.05 | Why? |
| Gene Rearrangement | 1 | 2018 | 84 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Muscle Proteins | 1 | 2018 | 64 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Mental Status Schedule | 1 | 2017 | 34 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.04 | Why? |
| Molecular Conformation | 1 | 2019 | 374 | 0.04 | Why? |
| Sleep Stages | 1 | 2017 | 52 | 0.04 | Why? |
| Porphyrins | 1 | 2018 | 88 | 0.04 | Why? |
| Mechanotransduction, Cellular | 1 | 2017 | 28 | 0.04 | Why? |
| Brain Neoplasms | 1 | 2005 | 669 | 0.04 | Why? |
| Erythrocyte Membrane | 1 | 2017 | 56 | 0.04 | Why? |
| Tendons | 1 | 2017 | 43 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Cell Line | 3 | 2018 | 12040 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2018 | 335 | 0.04 | Why? |
| Vibration | 1 | 2017 | 68 | 0.04 | Why? |
| Metabolic Networks and Pathways | 1 | 2019 | 285 | 0.04 | Why? |
| Simeprevir | 1 | 2017 | 62 | 0.04 | Why? |
| Fatty Acids, Unsaturated | 1 | 2017 | 70 | 0.04 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 187 | 0.04 | Why? |
| Stress, Mechanical | 1 | 2017 | 143 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.04 | Why? |
| Mice, SCID | 1 | 2017 | 225 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Bioreactors | 1 | 2017 | 115 | 0.04 | Why? |
| Animals | 5 | 2018 | 78931 | 0.04 | Why? |
| Adenosine Triphosphate | 1 | 2019 | 294 | 0.04 | Why? |
| Pedigree | 1 | 2018 | 502 | 0.04 | Why? |
| Biomimetic Materials | 1 | 2017 | 70 | 0.04 | Why? |
| Calibration | 1 | 2017 | 307 | 0.04 | Why? |
| Metals | 1 | 2018 | 182 | 0.04 | Why? |
| Hematologic Tests | 1 | 2021 | 521 | 0.04 | Why? |
| Creatine Kinase | 1 | 2018 | 386 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Posture | 1 | 2017 | 199 | 0.04 | Why? |
| Extracellular Matrix | 1 | 2017 | 189 | 0.04 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.04 | Why? |
| Gene Frequency | 1 | 2020 | 1210 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2019 | 1008 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.04 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.04 | Why? |
| Protein Processing, Post-Translational | 1 | 2018 | 634 | 0.04 | Why? |
| Nerve Degeneration | 1 | 2014 | 73 | 0.04 | Why? |
| Lysosomes | 1 | 2018 | 416 | 0.03 | Why? |
| Hydrogen-Ion Concentration | 1 | 2018 | 993 | 0.03 | Why? |
| Metabolome | 1 | 2019 | 624 | 0.03 | Why? |
| Pregnancy Trimester, First | 1 | 2016 | 366 | 0.03 | Why? |
| Proteome | 1 | 2005 | 1812 | 0.03 | Why? |
| Eating | 1 | 2017 | 395 | 0.03 | Why? |
| Alleles | 1 | 2020 | 1557 | 0.03 | Why? |
| Placebos | 1 | 2017 | 629 | 0.03 | Why? |
| Blood Specimen Collection | 1 | 2018 | 387 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.03 | Why? |
| Platelet Count | 1 | 2020 | 1381 | 0.03 | Why? |
| Glucose | 1 | 2018 | 573 | 0.03 | Why? |
| Calcium | 1 | 2019 | 708 | 0.03 | Why? |
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 133 | 0.03 | Why? |
| Eosinophils | 1 | 2020 | 848 | 0.03 | Why? |
| Oligopeptides | 1 | 2017 | 576 | 0.03 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2020 | 1061 | 0.03 | Why? |
| Reference Standards | 1 | 2017 | 1163 | 0.03 | Why? |
| Hand | 1 | 2017 | 449 | 0.03 | Why? |
| Homeostasis | 1 | 2016 | 582 | 0.03 | Why? |
| Cell Culture Techniques | 1 | 2017 | 704 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2019 | 2219 | 0.03 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.03 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2019 | 1475 | 0.03 | Why? |
| Sofosbuvir | 1 | 2017 | 518 | 0.03 | Why? |
| Nose | 1 | 2018 | 1093 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2017 | 802 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.03 | Why? |
| Sweden | 1 | 2019 | 1969 | 0.03 | Why? |
| Carbon Dioxide | 1 | 2018 | 917 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Fibrinogen | 1 | 2017 | 1048 | 0.03 | Why? |
| Drug Synergism | 1 | 2014 | 833 | 0.03 | Why? |
| Gestational Age | 1 | 2016 | 1488 | 0.03 | Why? |
| Switzerland | 1 | 2019 | 2738 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2014 | 1027 | 0.03 | Why? |
| Printing, Three-Dimensional | 1 | 2017 | 624 | 0.03 | Why? |
| Autophagy | 1 | 2018 | 960 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Ribavirin | 1 | 2017 | 1182 | 0.03 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2017 | 1153 | 0.02 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Kinetics | 1 | 2017 | 3238 | 0.02 | Why? |
| Continuous Positive Airway Pressure | 1 | 2017 | 1187 | 0.02 | Why? |
| Physical Therapy Modalities | 1 | 2017 | 1090 | 0.02 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.02 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.02 | Why? |
| Mice | 2 | 2018 | 21357 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.02 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.02 | Why? |
| England | 1 | 2019 | 5116 | 0.02 | Why? |
| Up-Regulation | 1 | 2014 | 2249 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2019 | 6543 | 0.02 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.02 | Why? |
| Child | 3 | 2020 | 70012 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Ectoderm | 1 | 2005 | 3 | 0.02 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2019 | 4155 | 0.02 | Why? |
| Xenopus Proteins | 1 | 2005 | 12 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Receptors, Fibroblast Growth Factor | 1 | 2005 | 14 | 0.02 | Why? |
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2005 | 10 | 0.02 | Why? |
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 40 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2014 | 3608 | 0.02 | Why? |
| Wounds and Injuries | 1 | 2018 | 1708 | 0.02 | Why? |
| Topoisomerase II Inhibitors | 1 | 2005 | 36 | 0.02 | Why? |
| DNA Fragmentation | 1 | 2005 | 67 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Tumor Cells, Cultured | 1 | 2005 | 254 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Oxygen | 1 | 2018 | 3715 | 0.02 | Why? |
| Interferons | 1 | 2017 | 2885 | 0.02 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2019 | 6902 | 0.02 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 243 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2016 | 3803 | 0.02 | Why? |
| Cell Death | 1 | 2005 | 536 | 0.01 | Why? |
| Protein Binding | 1 | 2019 | 11430 | 0.01 | Why? |
| France | 1 | 2019 | 12074 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Brain | 1 | 2019 | 5133 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Eye | 1 | 2005 | 374 | 0.01 | Why? |
| Spain | 1 | 2019 | 15545 | 0.01 | Why? |
| Venous Thromboembolism | 1 | 2018 | 4273 | 0.01 | Why? |
| Mass Spectrometry | 1 | 2005 | 1165 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.01 | Why? |
| Immunohistochemistry | 1 | 2005 | 2275 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Pregnancy | 1 | 2016 | 23879 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2005 | 8041 | 0.00 | Why? |